Treatment of HEPAtic diseases with inNOVAtive solutions.
Hepanova has raised $1.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
Hepanova's investors include Shenzhen Capital Group, Pudong Innotek.
Hepanova is headquartered in Gaithersburg, United States.
Treatment of HEPAtic diseases with inNOVAtive solutions.
Hepanova is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hepanova — Funding & Investors." VCBacked, April 15, 2023, https://www.vcbacked.co/company/hepanova. Accessed November 12, 2026.
VCBacked. (2023). Hepanova — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/hepanova
{{cite web |title=Hepanova — Funding & Investors |url=https://www.vcbacked.co/company/hepanova |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Hepanova? Request a listing update